Differential diagnosis of imaging alterations after stereotactic radiotherapy of brain metastases: A narrative review

IF 1.3 4区 医学 Q4 ONCOLOGY
Cancer Radiotherapie Pub Date : 2026-07-01 Epub Date: 2026-08-12 DOI:10.1016/j.canrad.2026.104859
Lara Caglayan, Mathias Sempels, Lieselotte Lauwens, Jean-François Daisne
{"title":"Differential diagnosis of imaging alterations after stereotactic radiotherapy of brain metastases: A narrative review","authors":"Lara Caglayan,&nbsp;Mathias Sempels,&nbsp;Lieselotte Lauwens,&nbsp;Jean-François Daisne","doi":"10.1016/j.canrad.2026.104859","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Stereotactic radiotherapy is a key treatment for brain metastases, alongside surgery and systemic therapies. A substantial proportion of patients develop radiation necrosis after stereotactic radiotherapy. Differentiating radiation necrosis from tumour progression is critical, as they require distinct therapeutic strategies. While magnetic resonance imaging remains the mainstay of surveillance, its limitations emphasize the need for alternative, non-invasive diagnostic modalities. This narrative review aimed to summarize recent imaging techniques for distinguishing radiation necrosis from tumour progression after stereotactic radiotherapy for brain metastases.</div></div><div><h3>Materials and methods</h3><div>A systematic literature search was conducted in Embase and Medline (using the search engine PubMed) for studies published between January 2012 and February 2025. The terms “radiation necrosis,” “brain metastasis,” and “diagnosis” were combined. Eligible studies included adult patients with brain metastases treated with stereotactic radiation, with differentiation of radiation necrosis from tumour progression assessed by histopathology or imaging follow-up. Studies exclusively on primary brain tumours or without separate brain metastases analysis were excluded. Both prospective and retrospective designs were considered.</div></div><div><h3>Results</h3><div>Fourty studies met inclusion criteria: magnetic resonance imaging (<em>n</em> <!-->=<!--> <!-->21), nuclear medicine (<em>n</em> <!-->=<!--> <!-->13), and radiomics (<em>n</em> <!-->=<!--> <!-->6). Advanced magnetic resonance imaging (e.g., perfusion, intravoxel incoherent motion, treatment response assessment maps) and aminoacid positron-emission tomography showed the highest diagnostic accuracies. Radiomics, especially multiparametric approaches, improved performance but lacked external validation.</div></div><div><h3>Conclusion</h3><div>Combined advanced magnetic resonance imaging, aminoacid positron-emission tomography, and radiomics approaches offer the greatest potential. Prospective studies are needed.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"30 4","pages":"Article 104859"},"PeriodicalIF":1.3000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Radiotherapie","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1278321826000624","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/12 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

Stereotactic radiotherapy is a key treatment for brain metastases, alongside surgery and systemic therapies. A substantial proportion of patients develop radiation necrosis after stereotactic radiotherapy. Differentiating radiation necrosis from tumour progression is critical, as they require distinct therapeutic strategies. While magnetic resonance imaging remains the mainstay of surveillance, its limitations emphasize the need for alternative, non-invasive diagnostic modalities. This narrative review aimed to summarize recent imaging techniques for distinguishing radiation necrosis from tumour progression after stereotactic radiotherapy for brain metastases.

Materials and methods

A systematic literature search was conducted in Embase and Medline (using the search engine PubMed) for studies published between January 2012 and February 2025. The terms “radiation necrosis,” “brain metastasis,” and “diagnosis” were combined. Eligible studies included adult patients with brain metastases treated with stereotactic radiation, with differentiation of radiation necrosis from tumour progression assessed by histopathology or imaging follow-up. Studies exclusively on primary brain tumours or without separate brain metastases analysis were excluded. Both prospective and retrospective designs were considered.

Results

Fourty studies met inclusion criteria: magnetic resonance imaging (n = 21), nuclear medicine (n = 13), and radiomics (n = 6). Advanced magnetic resonance imaging (e.g., perfusion, intravoxel incoherent motion, treatment response assessment maps) and aminoacid positron-emission tomography showed the highest diagnostic accuracies. Radiomics, especially multiparametric approaches, improved performance but lacked external validation.

Conclusion

Combined advanced magnetic resonance imaging, aminoacid positron-emission tomography, and radiomics approaches offer the greatest potential. Prospective studies are needed.
脑转移瘤立体定向放疗后影像学改变的鉴别诊断:一篇叙述性综述
目的立体定向放疗是除手术和全身治疗外治疗脑转移瘤的关键方法。相当比例的患者在立体定向放疗后发生放射性坏死。区分放射性坏死和肿瘤进展是至关重要的,因为它们需要不同的治疗策略。虽然磁共振成像仍然是监测的主要手段,但其局限性强调需要替代的非侵入性诊断方式。本文综述了脑转移瘤立体定向放疗后放射坏死与肿瘤进展的最新影像学技术。材料与方法在Embase和Medline(使用PubMed搜索引擎)中对2012年1月至2025年2月间发表的研究进行系统的文献检索。术语“放射性坏死”、“脑转移”和“诊断”被合并在一起。符合条件的研究包括接受立体定向放射治疗的成年脑转移患者,通过组织病理学或影像学随访评估放射坏死与肿瘤进展的区别。排除了仅针对原发性脑肿瘤或没有单独脑转移分析的研究。前瞻性和回顾性设计均被考虑。结果40项研究符合纳入标准:磁共振成像(n = 21)、核医学(n = 13)和放射组学(n = 6)。先进的磁共振成像(如灌注、体素内非相干运动、治疗反应评估图)和氨基酸正电子发射断层扫描显示出最高的诊断准确性。放射组学,特别是多参数方法,提高了性能,但缺乏外部验证。结论先进的磁共振成像、氨基酸正电子发射断层扫描和放射组学相结合的方法具有很大的应用潜力。前瞻性研究是必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Radiotherapie
Cancer Radiotherapie 医学-核医学
CiteScore
2.20
自引率
23.10%
发文量
129
审稿时长
63 days
期刊介绍: Cancer/radiothérapie se veut d''abord et avant tout un organe francophone de publication des travaux de recherche en radiothérapie. La revue a pour objectif de diffuser les informations majeures sur les travaux de recherche en cancérologie et tout ce qui touche de près ou de loin au traitement du cancer par les radiations : technologie, radiophysique, radiobiologie et radiothérapie clinique.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书